Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period

Transplantation

Volumn 96, Issue 1, 2013, Pages 70-78

  Sánchez Zapardiel, Elena ^a   Castro Panete, María J ^a   Castillo Rama, Marcela ^a   Morales, Pablo ^a   Lora Pablos, David ^a   Valero Hervás, Diana ^a   Ruiz García, Raquel ^a   Apaza, Jacqueline ^a   Talayero, Paloma ^a   Andrés, Amado ^a   Morales, José M ^a   Paz Artal, Estela ^a,b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Anti MICA antibodies; Pretransplantation; Rejection; Renal transplant

Indexed keywords

ALLOANTIBODY; HLA ANTIBODY; HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN RELATED MOLECULE A ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; DISEASE DURATION; FEMALE; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; PREGNANCY OUTCOME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIZATION; SURGICAL RISK;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; WAITING LISTS; YOUNG ADULT;

EID: 84879841774     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182943506     Document Type: Article

References (27)

1. Otten HG, Verhaar MC, Borst HP, et al. Pretransplant donor-specific HLA class-I and -II antibodies are associated with an increased risk for kidney graft failure. Am J Transplant 2012; 12: 1618.
2. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280: 735.
3. Terasaki P. Humoral theory of transplantation. Am J Transplant 2003; 3: 665.
4. Zhang Q, Reed EF. Non-MHC antigenic targets of the humoral immune response in transplantation. Curr Opin Immunol 2010; 22: 682.
5. Dragun D, Philippe A, Catar R. Role of non-HLA antibodies in organ transplantation. Curr Opin Organ Transplant 2012; 17: 440.
6. Win TS, Pettigrew GJ. Humoral autoimmunity and transplant vasculopathy: when allo is not enough. Transplantation 2010; 90: 113.
7. Zwirner NW, Fernandez-Vina MA, Stastny P. MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. Immunogenetics 1998; 47: 139.
8. Zou Y, Mirbaha F, Lazaro A, et al. MICA is a target for complementdependent cytotoxicity with mouse monoclonal antibodies and human alloantibodies. Hum Immunol 2002; 63: 30.
9. Schrambach S, Ardizzone M, Leymarie V, et al. In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer. PloS ONE 2007; 2: e518.
10. Zou Y, Bresnahan W, Taylor RT, et al. Effect of human cytomegalovirus on expression of MHC class I-related chains A. J Immunol 2005; 174: 3098.
11. Caillat-Zucman S. How NKG2D ligands trigger autoimmunity? Hum Immunol 2006; 67: 204.
12. Groh V, Rhinehart R, Secrist H, et al. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci U S A 1999; 96: 6879.
13. Wei L, Lu J, Feng L, et al. Ischemia/reperfusion injury promotes MICA and MICB expression on human cardiac myocytes via HIF-1 pathway. Am J Transplant 2009; 576.
14. Luo L, Lu J, Wei L, et al. The role of HIF-1 in up-regulating MICA expression on human renal proximal tubular epithelial cells during hypoxia/reoxygenation. BMC Cell Biol 2010; 11: 91.
15. Zwirner NW, Marcos CY, Mirbaha F, et al. Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol 2000; 61: 917.
16. Sumitran-Holgersson S, Wilczek HE, Holgersson J, et al. Identification of the nonclassical HLA molecules, MICA, as targets for humoral immunity associated with irreversible rejection of kidney allografts. Transplantation 2002; 74: 268.
17. Zou Y, Stastny P, Susal C, et al. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 2007; 357: 1293.
18. Cox ST, Stephens HA, Fernando R, et al. Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation. Hum Immunol 2011; 72: 827.
19. Mizutani K, Terasaki P, Rosen A, et al. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant 2005; 5: 2265.
20. Terasaki PI, Ozawa M, Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 2007; 7: 408.
21. Amezaga N, Crespo M, Lopez-Cobos M, et al. Relevance of MICA antibodies in acute humoral rejection in renal transplant patients. Transpl Immunol 2006; 17: 39.
22. Lemy A, Andrien M, Wissing KM, et al. Major histocompatibility complex class 1 chain-related antigen a antibodies: sensitizing events and impact on renal graft outcomes. Transplantation 2010; 90: 168.
23. Lemy A, Andrien M, Lionet A, et al. Posttransplant major histocompatibility complex class I chain-related gene A antibodies and longterm graft outcomes in a multicenter cohort of 779 kidney transplant recipients. Transplantation 2012; 93: 1258.
24. Zou Y, Heinemann FM, Grosse-Wilde H, et al. Detection of anti- MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry. Hum Immunol 2006; 67: 230.
25. Solgi G, Furst D, Mytilineos J, et al. Clinical relevance of pre and posttransplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA. Transpl Immunol 2012; 26: 81.
26. Groh V, Rhinehart R, Randolph-Habecker J, et al. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2001; 2: 255.
27. Gratwohl V, Döhler R, Stern J, et al. H-Yas a minor histocompatibility antigen in kidney transplantation: a retrospective cohort study. Lancet 2008; 372: 49.